Citigroup’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.9K | Sell |
|
|||||
|
2025
Q2 | $90.1K | Sell |
|
|||||
|
2025
Q1 | $168K | Sell |
|
|||||
|
2024
Q4 | $344K | Buy |
|
|||||
|
2024
Q3 | $287K | Buy |
|
|||||
|
2024
Q2 | $79K | Sell |
|
|||||
|
2024
Q1 | $798K | Buy |
|
|||||
|
2023
Q4 | $46.9K | Buy |
|
|||||
|
2023
Q3 | $490 | Sell |
|
|||||
|
2023
Q2 | $101K | Sell |
|
|||||
|
2023
Q1 | $899K | Buy |
|
|||||
|
2022
Q4 | $690K | Buy |
|
|||||
|
2022
Q3 | $25K | Buy |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $4K | Sell |
|
|||||
|
2021
Q4 | $41K | Buy |
|